Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.

Autor:	Mair RD; Department of Medicine, Stanford University, Palo Alto, California.; Department of Medicine, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California., Lee S; Department of Medicine, Stanford University, Palo Alto, California.; Department of Medicine, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California., Plummer NS; Department of Medicine, Stanford University, Palo Alto, California.; Department of Medicine, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California., Sirich TL; Department of Medicine, Stanford University, Palo Alto, California.; Department of Medicine, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California., Meyer TW; Department of Medicine, Stanford University, Palo Alto, California.; Department of Medicine, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California.
Jazyk:	angličtina
Zdroj:	Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2021 Nov; Vol. 32 (11), pp. 2877-2884. Date of Electronic Publication: 2021 Aug 18.
DOI:	10.1681/ASN.2021030336
Abstrakt:	Background: The clearance of solutes removed by tubular secretion may be altered out of proportion to the GFR in CKD. Recent studies have described considerable variability in the secretory clearance of waste solutes relative to the GFR in patients with CKD. Methods: To test the hypothesis that secretory clearance relative to GFR is reduced in patients approaching dialysis, we used metabolomic analysis to identify solutes in simultaneous urine and plasma samples from 16 patients with CKD and an eGFR of 7±2 ml/min per 1.73 m 2 and 16 control participants. Fractional clearances were calculated as the ratios of urine to plasma levels of each solute relative to those of creatinine and urea in patients with CKD and to those of creatinine in controls. Results: Metabolomic analysis identified 39 secreted solutes with fractional clearance >3.0 in control participants. Fractional clearance values in patients with CKD were reduced on average to 65%±27% of those in controls. These values were significantly lower for 18 of 39 individual solutes and significantly higher for only one. Assays of the secreted anions phenylacetyl glutamine, p -cresol sulfate, indoxyl sulfate, and hippurate confirmed variable impairment of secretory clearances in advanced CKD. Fractional clearances were markedly reduced for phenylacetylglutamine (4.2±0.6 for controls versus 2.3±0.6 for patients with CKD; P <0.001), p -cresol sulfate (8.6±2.6 for controls versus 4.1±1.5 for patients with CKD; P <0.001), and indoxyl sulfate (23.0±7.3 versus 7.5±2.8; P <0.001) but not for hippurate (10.2±3.8 versus 8.4±2.6; P =0.13). Conclusions: Secretory clearances for many solutes are reduced more than the GFR in advanced CKD. Impaired secretion of these solutes might contribute to uremic symptoms as patients approach dialysis. (Copyright © 2021 by the American Society of Nephrology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu